INFLUENZINUM (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the INFLUENZINUM drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: INFLUENZINUM
SUBSTANCE NAME: INFLUENZA A VIRUS; INFLUENZA B VIRUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


INFLUENZINUM HUMAN OTC DRUG Details:

Item DescriptionINFLUENZINUM from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 9; 9([hp_C]/1; [hp_C]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-7126_357e9ef5-2455-4304-b7cc-7e4f1f4ca2e7
PRODUCT NDC: 60512-7126
APPLICATION NUMBER:

Other INFLUENZA A VIRUS; INFLUENZA B VIRUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Homeocare LaboratoriesInfluenzinum
HOMEOLAB USA INC.INFLUENZINUM